APA (7th ed.) Citation

Matthias, J., Engelhardt, J., Schäfer, M., Bauder-Wüst, U., Meyer, P. T., Haberkorn, U., . . . Eder, A. (2021). Cytoplasmic localization of prostate-specific membrane antigen inhibitors may confer advantages for targeted cancer therapies. Cancer research, 81(8), . https://doi.org/10.1158/0008-5472.CAN-20-1624

Chicago Style (17th ed.) Citation

Matthias, Jessica, et al. "Cytoplasmic Localization of Prostate-specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer Therapies." Cancer Research 81, no. 8 (2021). https://doi.org/10.1158/0008-5472.CAN-20-1624.

MLA (9th ed.) Citation

Matthias, Jessica, et al. "Cytoplasmic Localization of Prostate-specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer Therapies." Cancer Research, vol. 81, no. 8, 2021, https://doi.org/10.1158/0008-5472.CAN-20-1624.